The programme comprises two Phase III trials, ONWARD1 and ONWARD2, and an optional long-term extension trial, ONWARD3.

Most patients with psoriasis experienced clinical improvement or remission after metabolic and bariatric surgery (MBS) in a ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

A new clinical review explores the complexities of treating psoriasis during pregnancy and lactation highlighting limited ...

Dr. Jason Rivers, MD, FRCPC, discusses psoriasis symptoms and treatments. Russia, China, North Korea condemn Trump's $175 billion Golden Dome missile shield Pierce Brosnan defends Irish accent in MobL ...

Among 25 different measures of adiposity, abdominal fat was significantly associated with a risk for psoriasis. Among 25 ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

Inflammation tends to remain in people with psoriasis, despite their skin responding well to treatment with biologics, latest ...

Skin symptoms may clear with biologics in psoriasis, but hidden internal inflammation often persists, contributing to major ...

The study revealed the following findings: 36.3% of psoriasis patients had elevated high-sensitivity C-reactive protein ...

Learn to distinguish between nail psoriasis and nail fungus through key visual differences, associated symptoms, and ...